In this video, Peter Chin, MD, discusses the findings of the study, “Evolution of the Zenflow Spring System: A novel nitinol implant for benign prostatic hyperplasia (BPH),” presented at the 2021 American Urological Association Annual Meeting. He also discusses the investigational Zenflow Spring System’s associated advantages from the study. Chin is an associate professor at the University of Wollongong, New South Wales, Australia.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.